Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brent Akio Hiramoto, M.B.

Concepts (51)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Eosinophilic Esophagitis220211680.800 Why?
Gastroesophageal Reflux220237820.690 Why?
Celiac Disease120217850.450 Why?
Manometry320244450.290 Why?
Esophageal pH Monitoring220231910.260 Why?
Pancreatitis2202110920.230 Why?
Esophageal Motility Disorders12023440.220 Why?
Esophagitis, Peptic12023780.210 Why?
Defecation120241880.210 Why?
Quality of Life12023128020.210 Why?
Anal Canal120243760.190 Why?
Enteritis120211650.180 Why?
Electric Impedance120237290.170 Why?
Gastritis120211960.170 Why?
Resuscitation220216580.170 Why?
Systemic Inflammatory Response Syndrome220216120.160 Why?
Esophageal Stenosis120201950.160 Why?
Eosinophilia120215410.140 Why?
Coloring Agents120185660.140 Why?
Endoscopy, Gastrointestinal120218680.130 Why?
Lung Transplantation1202311550.120 Why?
Primary Prevention1201811670.100 Why?
Guideline Adherence1201822650.080 Why?
Prevalence22021152210.070 Why?
Fluid Therapy220215930.070 Why?
Acute Coronary Syndrome1201823370.060 Why?
Obesity22024127460.060 Why?
Adult620242140520.060 Why?
Retrospective Studies52024774600.050 Why?
Practice Guidelines as Topic1201872820.050 Why?
Isotonic Solutions120211190.050 Why?
Constipation120245460.040 Why?
Prospective Studies12023532900.040 Why?
Rectum120249040.040 Why?
Acidosis120202700.040 Why?
Infusions, Intravenous1202022740.030 Why?
Humans820247443660.030 Why?
Patient Admission1202013800.030 Why?
Acute Disease1202171470.020 Why?
Intensive Care Units1202036800.020 Why?
Length of Stay1202063110.020 Why?
Double-Blind Method12020120250.020 Why?
Randomized Controlled Trials as Topic1202199550.020 Why?
Severity of Illness Index12020155350.010 Why?
Middle Aged320232133900.010 Why?
Male320243501150.010 Why?
Female320243801930.010 Why?
Risk Assessment12018233360.010 Why?
Treatment Outcome12020631070.010 Why?
United States12018698720.010 Why?
Aged120181632880.000 Why?
Hiramoto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (51)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.